nadequate closure of the dura in craniotomies increases the risk of CSF leakage, infection, meningitis, subsequent neurological deficits, and even death.
Methods
A retrospective analysis examining pediatric patients (age 0-18 years) who underwent cranial surgery at The Johns Hopkins Hospital during the period from August 2005 to July 2010 was performed. In all cases reviewed, the primary indication for the use of PEG sealant was as an adjunct to standard sutured dural closure techniques. A total of 163 patients were identified, and all documentation in the electronic patient record, including operative reports and clinical notes concerning the first 90 postoperative days, was analyzed to determine and record any postoperative complications, including CSF leak, operative revision/repair, pseudomeningocele repair, surgical site infection, meningitis, neurological deficit, or death. Basic demographic information, including age, sex, date of surgery, indication for surgery, and surgical approach (supratentorial, infratentorial, or transsphenoidal), was collected from documentation in the electronic patient record. Immediately after surgery all patients were kept with the head of bed raised at least 30° with no restrictions. The Johns Hopkins Institutional Review Board issued approval for this study.
Results
This study analyzed 92 males and 71 females, with an average age of 10.2 ± 4.34 years. We used PEG sealant in 12 patients (7.4%) who were 0-2 years of age, 19 patients (11.7%) 2-4.9 years of age, 43 patients (26.4%) 5-9.9 years of age, 54 patients (33.1%) 10-14.9 years of age, and 35 patients (21.5%) 15-19.9 years of age ( Table  1) . There were 88 patients who underwent supratentorial surgery, 72 patients who underwent infratentorial surgery, and 3 patients who underwent transsphenoidal surgery. Of these 163 patients, 40 (24.5%) underwent surgical treatment for diagnosis of a supratentorial tumor, 38 (23.3%) for Chiari malformation, 34 (20.9%) for an infratentorial tumor, 33 (20.2%) for epilepsy, 8 (4.9%) for a cranioplasty with dural closure, 6 (3.7%) for open sellar lesions such as craniopharyngiomas, 3 (1.8%) for transsphenoidal resection of a sellar tumor, and 1 (0.6%) for a supratentorial cavernous malformation (Table 2) .
Evaluating the cohort's 90-day postoperative clinical course, we found that 4 patients (2.4%) required revision surgery and 2 patients (1.2%) developed a CSF leak. Four patients (2.4%) developed superficial skin infections, 1 patient developed postoperative meningitis (0.6%), and 158 patients (96.9%) did not develop an infection. There were no deaths or neurological deficits within this time period in our series (Table 3) . PEG sealant was used in all cases independent of whether an autologous or nonautologous graft was used. In the 163 patients analyzed, an autologous graft was used in 8 patients (4.9%), a nonautologous graft was used in 63 patients (38.7%), and no graft was used in 92 patients (56.4%). The complication rate in patients with no graft was 2.2% overall and 1.2% in this subgroup, whereas patients who had a nonautologous graft placed at the time of surgery had a complication rate of 4.8% in this subgroup and 1.8% overall. There were no complications in the subset of patients who were treated with an autologous graft in this series (Table 4) .
Of the 4 patients who required revision surgery, 2 patients underwent a suboccipital craniotomy for resection of a posterior fossa tumor, 1 patient underwent a left craniotomy for a supratentorial lesion, and 1 patient presented following a cranioplasty. The patient who developed postoperative meningitis underwent a Chiari decompression with placement of a nonautologous dural graft. Both patients with CSF leak had posterior fossa tumors that were resected. One of these patients with a CSF leak had known hydrocephalus prior to the procedure.
Discussion
This retrospective review of pediatric patients who underwent cranial surgery found that PEG sealant in combination with standard dural closure techniques had an overall 6.7% complication rate and a 1.2% CSF leak rate. Evaluating the cohort's 90-day postoperative clinical course, we found that 4 patients (2.4%) developed superficial skin infections, 1 patient developed meningitis, and 158 patients (96.9%) did not develop an infection. Four patients (2.4%) required revision surgery. There were no deaths or neurological deficits within this time period in our series. This demonstrates the safety and low complication rate associated with PEG sealant use. Two patients (1.2%) developed a CSF leak, which is comparable to the 1.3% rate noted in other pediatric neurosurgery studies that have used PEG sealant (range 1.3%-17.5%). 4, 6, 11, 14 Other studies examining CSF leak rate with PEG sealant were limited to adult cohorts but also reported a comparable leak rate. Boogaarts et al. reported a 2.2% CSF leak rate in a nonrandomized, prospective trial; 2 Cosgrove et al., 1.8% in a prospective trial; 5 Weinstein et al., 7.6% in a retrospective review; 15 Than et al., 2% in a prospective review; 13 and Osbun et al., 0.8% in a prospective randomized trial.
9 Our findings and corroborating results from other studies demonstrate that PEG sealant use in combination with standard dural closure is safe for cranial procedures.
There are many considerations for establishment and incorporation of PEG sealant use as part of standard dural closure technique, including cost savings, reductions in complications, and decreased readmission. Grotenhuis projected substantial cost savings with prophylactic use of PEG sealant due to a reduction in the incidence of postoperative CSF leaks. 8 Another consideration is the interaction of PEG sealant with other materials used in dural closure. Parker et al. reported an increased rate of aseptic meningitis and/or CSF leak when tissue sealant was used in combination with a dural substitute for pediatric posterior fossa decompression with duraplasty. They attributed this finding to increased inflammation. 10 In our review, the complication rate in patients with no graft was 2.2% overall, compared with a 1.8% overall complication rate in patients who had a nonautologous graft placed at the time of surgery. There were no complications in the subset of patients who were treated with an autologous graft in this series.
Conclusions
This study demonstrates the safety and low complication rates of PEG sealant used in combination with standard suture repair in pediatric cranial neurosurgery cases. Based on this preliminary study, a large randomized controlled multi-institution trial is needed to evaluate potential efficacy and benefits of PEG sealant use for dural closure in pediatric cranial neurosurgery procedures. 
